COVID-19
Not recruitingStudy of GS-5245 for Treating COVID-19 in Children and Adolescents
Study of GS-5245 for Treating COVID-19 in Children and Adolescents
Spain- Participants:0–17 years
- Substances:GS-5245
- Sponsor:Gilead Sciences Inc.
Rare diseases
Investigational molecules
Locations
Back to Spain3 275 clinical trials in Pozuelo De Alarcon, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study of GS-5245 for Treating COVID-19 in Children and Adolescents
SpainStudy Comparing Enfortumab Vedotin and Pembrolizumab with Chemotherapy for Patients with Muscle-Invasive Bladder Cancer
SpainStudy of Adagrasib Dosing in Patients with Previously Treated Non-Small Cell Lung Cancer with KRAS G12C Mutation
SpainStudy Comparing SGN-B6A and Docetaxel for Adults with Previously Treated Non-Small Cell Lung Cancer
SpainStudy on Brentuximab Vedotin and Drug Combination for Patients with Peripheral T-cell Lymphoma with Less Than 10% CD30 Expression
SpainStudy on the Effectiveness and Safety of SAR441566 for Adults with Moderate to Severe Plaque Psoriasis
SpainStudy of JDQ443 and Ribociclib in Combination for Adult Patients with Advanced Solid Tumors with KRAS G12C Mutation
SpainStudy on the Effectiveness and Safety of Eneboparatide, Calcitriol, and Calcium Carbonate for Patients with Chronic Hypoparathyroidism
SpainStudy of Acalabrutinib, Venetoclax, and Rituximab for Patients with Newly Diagnosed Mantle Cell Lymphoma
SpainStudy on the Effectiveness and Safety of Autogene Cevumeran, Atezolizumab, and mFOLFIRINOX in Patients with Resected Pancreatic Cancer
SpainStudy on the Effectiveness and Safety of CAM2029 Compared to Octreotide and Lanreotide in Patients with Gastroenteropancreatic Neuroendocrine Tumors
SpainStudy of Pembrolizumab, MK-4830, and Chemotherapy for Patients with High-Grade Serous Ovarian Cancer
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on multiple cancer types including bladder cancer, pancreatic adenocarcinoma, and non-small cell lung cancer. Studies evaluate novel combination therapies and targeted treatments.
Research includes immunotherapy approaches and antibody-drug conjugates for improved treatment outcomes.
Clinical investigations in respiratory conditions, including studies of RSV prevention in high-risk infants and novel treatments for uncontrolled asthma. Research focuses on innovative therapeutic approaches.
Studies evaluate both preventive measures and treatment interventions.
Research targeting neurological conditions, with emphasis on Alzheimer's Disease and Multiple Sclerosis. Studies focus on disease-modifying therapies and novel treatment approaches.
Investigations aim to slow disease progression and improve patient outcomes.
Studies in blood disorders including acute myeloid leukemia and immune thrombocytopenia. Research evaluates new therapeutic approaches and combination treatments.
Focus on improving survival rates and treatment efficacy.
Tell us about your condition – we search every trial in Europe and connect you with the right site.